United States · FDA National Drug Code directory
Oxaliplatin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61703-363_4edbffab-0628-4c35-ac6a-76a629f3c9dd
- Product NDC
- 61703-363
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- OXALIPLATIN
- Labeler
- Hospira, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090810
- Source listing expiry
- 20271231
Source-listed ingredients
- OXALIPLATIN — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-363-18) / 10 mL in 1 VIAL, SINGLE-DOSE · 61703-363-18
- 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-363-22) / 20 mL in 1 VIAL, SINGLE-DOSE · 61703-363-22
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →